Betekenis van:
hepatitis b

hepatitis b
Zelfstandig naamwoord
    • an acute (sometimes fatal) form of viral hepatitis caused by a DNA virus that tends to persist in the blood serum and is transmitted by sexual contact or by transfusion or by ingestion of contaminated blood or other bodily fluids

    Synoniemen

    Hyperoniemen


    Voorbeeldzinnen

    1. Hepatitis B
    2. HEPATITIS B, ACUTE (Hepatitis B virus)
    3. HEPATITIS B, ACUTE
    4. (Hepatitis B virus)
    5. Hepatitis B vaccines
    6. Anti-HIV-1,2 Hepatitis B
    7. Hepatitis B virus core IgM antigen specific antibody response
    8. Children of mothers with HIV, hepatitis B, hepatitis C or HTLV infection, or at risk of such infection, and who have not been breastfed by their mothers during the previous 12 months and for whom analytical tests, physical examinations, and reviews of medical records do not provide evidence of HIV, hepatitis B, hepatitis C or HTLV infection, can be accepted as donors.
    9. History, clinical evidence, or laboratory evidence of HIV, acute or chronic hepatitis B (except in the case of persons with a proven immune status), hepatitis C and HTLV I/II, transmission risk or evidence of risk factors for these infections.
    10. where HIV 1 and 2, hepatitis B or hepatitis C test results are positive or unavailable, or where the donor is known to be a source of infection risk, a system of separate storage must be devised;
    11. Children aged less than 18 months born from mothers with HIV, hepatitis B, hepatitis C or HTLV infection, or at risk of such infection, and who have been breastfed by their mothers during the previous 12 months, cannot be considered as donors regardless of the results of the analytical tests.
    12. CTS for performance evaluation of reagents and reagent products for the detection, confirmation and quantification in human specimens of markers of HIV infection (HIV 1 and 2), HTLV I and II, and hepatitis B, C, D
    13. The clinical criteria of some diseases do not allude to the fact that many acute cases are asymptomatic, (e.g. hepatitis A, B and C, campylobacter, salmonellosis) although these cases may still be important from a public health perspective on national level.
    14. Reviewing the good practices in preventing drug-related blood-borne infectious diseases, in particular hepatitis (B/C), among injecting drug users to provide adequate guidance documents for practitioners and patients from different settings and vulnerable groups having taken into account an evaluation of the health, social, and economic impacts. [Financing mechanism: Call for proposals]
    15. CTS for the manufacturer’s release testing of reagents and reagent products for the detection, confirmation and quantification in human specimens of markers of HIV infection (HIV 1 and 2), HTLV I and II, and hepatitis B, C, D (Immunological assays only)